Unraveling the Neural Basis of Psychedelic Therapy
Welcome to the forefront of groundbreaking research within the Psychiatry Research Department at Stanford University. The Stanford Psychedelics and Consciousness Lab (PCL) is dedicated to an ever-growing mission: exploring the neurocognitive underpinnings of the therapeutic effects of psychedelic compounds.
Our Vision
At the PCL, we are dedicated to transforming mental health care by rigorously studying the impact of psychedelic compounds on the brain. Our team includes renowned researchers and clinicians, collaborating closely with top experts in psychiatry, neuroscience, and neurobiology. This research not only advances scientific knowledge but also opens up new avenues for innovative scalable treatments in mental health, offering significant value to the healthcare sector.
A Distinctive Approach
The PCL sets itself apart through our unwavering commitment to scientific rigor and an approach-agnostic methodology. Our focus is not confined to any specific approach or compound; instead, we prioritize any avenue that proves most effective, guided by empirical evidence and innovative thinking.
Our cutting-edge research is spearheading groundbreaking studies that boldly probe into the pathways through which psychedelic compounds and psychedelic-assisted therapies affect the brain’s structure, function, and neurochemistry. This research is not just theoretical— once we establish the ‘how’, we will move to the ‘what’, ‘who’, and ‘when’ to create personalized, precise, and safe treatments designed to make a tangible difference in the lives of those suffering from conditions like brain injury, PTSD, addiction, and more.
Safety and Ethics
At the PCL, we have an outspoken dedication to neuroethical responsibility. Supported by brilliant collaborators and scholars, we hope to set a high bar for the field. Alongside a commitment to innovation and intellectual boldness, we conduct our research under the strictest ethical standards, ensuring the safety and well-being of participants and maintaining the integrity of our scientific inquiry. This ethical framework not only guides our current studies but also shapes the future landscape of clinical psychedelic research.